357 related articles for article (PubMed ID: 17591548)
21. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
[TBL] [Abstract][Full Text] [Related]
22. Kinetic modelling using basis functions derived from two-tissue compartmental models with a plasma input function: general principle and application to [18F]fluorodeoxyglucose positron emission tomography.
Hong YT; Fryer TD
Neuroimage; 2010 May; 51(1):164-72. PubMed ID: 20156574
[TBL] [Abstract][Full Text] [Related]
23. The total amount of uptake may affect the input function: a theoretic approach about 18F-FDG PET imaging.
Laffon E; Marthan R
Nucl Med Biol; 2015 Sep; 42(9):724-7. PubMed ID: 25960434
[TBL] [Abstract][Full Text] [Related]
24. Quantification method in [18F]fluorodeoxyglucose brain positron emission tomography using independent component analysis.
Su KH; Wu LC; Liu RS; Wang SJ; Chen JC
Nucl Med Commun; 2005 Nov; 26(11):995-1004. PubMed ID: 16208178
[TBL] [Abstract][Full Text] [Related]
25. Uncertainty and sensitivity analysis of biokinetic models for radiopharmaceuticals used in nuclear medicine.
Li WB; Hoeschen C
Radiat Prot Dosimetry; 2010; 139(1-3):228-31. PubMed ID: 20185457
[TBL] [Abstract][Full Text] [Related]
26. Analysis of 2-[Fluorine-18]-Fluoro-2-deoxy-D-glucose uptake kinetics in PET studies of pulmonary inflammation.
Schroeder T; Melo MF; Venegas JG
Acad Radiol; 2011 Apr; 18(4):418-23. PubMed ID: 21292507
[TBL] [Abstract][Full Text] [Related]
27. Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: numerical and patient data evaluation.
Vanzi E; Berti V; Polito C; Freddi I; Comis G; Rubello D; Sorbi S; Pupi A
Nucl Med Commun; 2016 Aug; 37(8):849-59. PubMed ID: 27058363
[TBL] [Abstract][Full Text] [Related]
28. Image-derived input function in dynamic human PET/CT: methodology and validation with 11C-acetate and 18F-fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain.
Croteau E; Lavallée E; Labbe SM; Hubert L; Pifferi F; Rousseau JA; Cunnane SC; Carpentier AC; Lecomte R; Bénard F
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1539-50. PubMed ID: 20437239
[TBL] [Abstract][Full Text] [Related]
29. Comparative assessment of linear least-squares, nonlinear least-squares, and Patlak graphical method for regional and local quantitative tracer kinetic modeling in cerebral dynamic
Ben Bouallègue F; Vauchot F; Mariano-Goulart D
Med Phys; 2019 Mar; 46(3):1260-1271. PubMed ID: 30592540
[TBL] [Abstract][Full Text] [Related]
30. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
[TBL] [Abstract][Full Text] [Related]
31. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
Thorn SL; deKemp RA; Dumouchel T; Klein R; Renaud JM; Wells RG; Gollob MH; Beanlands RS; DaSilva JN
J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
[TBL] [Abstract][Full Text] [Related]
32. Estimation of an image derived input function with MR-defined carotid arteries in FDG-PET human studies using a novel partial volume correction method.
Sari H; Erlandsson K; Law I; Larsson HB; Ourselin S; Arridge S; Atkinson D; Hutton BF
J Cereb Blood Flow Metab; 2017 Apr; 37(4):1398-1409. PubMed ID: 27342321
[TBL] [Abstract][Full Text] [Related]
33. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
Muzi M; Vesselle H; Grierson JR; Mankoff DA; Schmidt RA; Peterson L; Wells JM; Krohn KA
J Nucl Med; 2005 Feb; 46(2):274-82. PubMed ID: 15695787
[TBL] [Abstract][Full Text] [Related]
34. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.
Schiffer WK; Mirrione MM; Dewey SL
J Nucl Med; 2007 Feb; 48(2):277-87. PubMed ID: 17268026
[TBL] [Abstract][Full Text] [Related]
35. Physiologic smoothing of blood time-activity curves for PET data analysis.
Graham MM
J Nucl Med; 1997 Jul; 38(7):1161-8. PubMed ID: 9225813
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive quantification of the differential portal and arterial contribution to the liver blood supply from PET measurements using the 11C-acetate kinetic model.
Chen S; Feng D
IEEE Trans Biomed Eng; 2004 Sep; 51(9):1579-85. PubMed ID: 15376506
[TBL] [Abstract][Full Text] [Related]
37. Multi-graphical analysis of dynamic PET.
Zhou Y; Ye W; Brasić JR; Wong DF
Neuroimage; 2010 Feb; 49(4):2947-57. PubMed ID: 19931403
[TBL] [Abstract][Full Text] [Related]
38. Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure.
Nishizawa S; Kuwabara H; Ueno M; Shimono T; Toyoda H; Konishi J
Ann Nucl Med; 2001 Jun; 15(3):203-7. PubMed ID: 11545189
[TBL] [Abstract][Full Text] [Related]
39. Comparison of eight methods for the estimation of the image-derived input function in dynamic [(18)F]-FDG PET human brain studies.
Zanotti-Fregonara P; Fadaili el M; Maroy R; Comtat C; Souloumiac A; Jan S; Ribeiro MJ; Gaura V; Bar-Hen A; Trébossen R
J Cereb Blood Flow Metab; 2009 Nov; 29(11):1825-35. PubMed ID: 19584890
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDOPA kinetics in brain tumors.
Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
